Lizanne M. Bruce
Lizanne M. Bruce's purchase track record
Lizanne M. Bruce has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/15/2021 | SLVM | $32K | +17.3% | +47.1% | -14.4% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 14, 2026
Sylvamo Price Targets Lowered by BofA and Truist. Bank of America and Truist Securities recently lowered their price targets for Sylvamo, citing updated outlooks. While BofA maintains a Neutral rating with a $42 target, Truist keeps a Buy rating but reduced its target to $40. These adjustments place the new targets below the current average analyst estimate of $50.40, reflecting a more cautious view on the company's near-term valuation.
Transaction History
| LPX | ▼ Sell | Other | 378 | $0 | 6/15/2026 | View on chart |
| LPX | ▼ Sell | Open Market | 1,141 | $89K | 6/15/2026 | View on chart |
| SLVM | ▼ Sell | Open Market | 1,230 | $51K | 6/15/2026 | View on chart |
| SLVM | ▲ Buy | Grant | 3,876 | $150K | 5/15/2026 | View on chart |
| LPX | ▲ Buy | Grant | 1,863 | $0 | 5/8/2026 | View on chart |
| LPX | ▼ Sell | Open Market | 1,300 | $102K | 3/10/2026 | View on chart |
| LPX | ▼ Sell | Other | 388 | $0 | 6/12/2025 | View on chart |
| SLVM | ▼ Sell | Open Market | 2,000 | $105K | 6/11/2025 | View on chart |
| LPX | ▼ Sell | Open Market | 1,179 | $106K | 6/11/2025 | View on chart |
| LPX | ▲ Buy | Grant | 1,499 | $0 | 5/15/2025 | View on chart |
| SLVM | ▲ Buy | Grant | 2,655 | $150K | 5/15/2025 | View on chart |
| LPX | ▼ Sell | Open Market | 532 | $60K | 12/16/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 1,968 | $224K | 12/16/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 2,500 | $246K | 9/16/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 1,409 | $126K | 6/17/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 1,313 | $116K | 6/17/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 869 | $78K | 6/17/2024 | View on chart |
| LPX | ▼ Sell | Other | 489 | $0 | 6/10/2024 | View on chart |
| LPX | ▲ Buy | Grant | 1,549 | $0 | 5/17/2024 | View on chart |
| SLVM | ▲ Buy | Grant | 1,779 | $125K | 5/16/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 572 | $44K | 3/15/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 1,576 | $123K | 3/15/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 352 | $28K | 3/15/2024 | View on chart |
| LPX | ▼ Sell | Open Market | 3,313 | $222K | 12/14/2023 | View on chart |
| LPX | ▼ Sell | Other | 369 | $0 | 7/6/2023 | View on chart |
| SLVM | ▲ Buy | Grant | 2,963 | $0 | 5/16/2023 | View on chart |
| LPX | ▲ Buy | Grant | 2,182 | $0 | 5/5/2023 | View on chart |
| LPX | ▼ Sell | Open Market | 3,587 | $224K | 12/15/2022 | View on chart |
| LPX | ▼ Sell | Other | 465 | $0 | 5/17/2022 | View on chart |
| SLVM | ▲ Buy | Grant | 2,623 | $0 | 5/16/2022 | View on chart |
| LPX | ▲ Buy | Option Exercise | 7,635 | $68K | 5/5/2022 | View on chart |
| LPX | ▼ Sell | Open Market | 7,635 | $573K | 5/5/2022 | View on chart |
| LPX | ▲ Buy | Grant | 1,733 | $0 | 5/4/2022 | View on chart |
| SLVM | ▲ Buy | Open Market | 1,000 | $32K | 11/15/2021 | View on chart |
| SLVM | ▲ Buy | Grant | 2,809 | $0 | 10/15/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 9, 2026
LPX Faces Analyst Downgrade and Upcoming Q3 Results
LPX has been highlighted as a trending stock and has posted returns that outpace the broader market, according to recent Yahoo reports. Barclays keeps an overweight rating but lowered its price target to $88, while SeekingAlpha has issued a downgrade, reflecting mixed analyst sentiment. The company will announce its third‑quarter 2026 results on Nov. 3, and the stock is currently near a key support level of $70.24 with an RSI of 43.3, indicating neither overbought nor oversold conditions.
LPX Faces Analyst Downgrade and Upcoming Q3 Results. LPX has been highlighted as a trending stock and has posted returns that outpace the broader market, according to recent Yahoo reports. Barclays keeps an overweight rating but lowered its price target to $88, while SeekingAlpha has issued a downgrade, reflecting mixed analyst sentiment. The company will announce its third‑quarter 2026 results on Nov. 3, and the stock is currently near a key support level of $70.24 with an RSI of 43.3, indicating neither overbought nor oversold conditions.